comparemela.com

Latest Breaking News On - ஆவணம் பாதுகாப்பு அமைப்புகள் - Page 9 : comparemela.com

Document Security Systems, Inc Closes $24 0 Million Upsized Public Offering of Common Stock

Document Security Systems, Inc. Closes $24.0 Million Upsized Public Offering of Common Stock ROCHESTER, N.Y., Jan. 22, 2021 (GLOBE NEWSWIRE) Document Security Systems, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the closing of an upsized underwritten public offering with gross proceeds to the Company of approximately $24.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The Company issued 6,666,666 shares of common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs.

Security Papers Market 2021: Industry Size, Share, Trends, Growth Insights, Major Factors, Top Manufacturers, Future Scenario, Recent Developments and Forecast Research

DSS Wholly Owned Subsidiary Impact BioMedical Announces Exclusive Distribution Agreement with

Press release content from Globe Newswire. The AP news staff was not involved in its creation. DSS Wholly Owned Subsidiary Impact BioMedical Announces Exclusive Distribution Agreement with . Document Security Systems Inc.December 23, 2020 GMT ROCHESTER, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) entered into a 10-year exclusive distribution agreement (the “Distribution Agreement”) with BioMed Technology Asia Pacific Holdings Limited (“BioMed”), a limited liability company incorporated in the British Virgin Islands. BioMed is the holding company of BioMed Technology Holdings Limited which focuses on manufacturing natural probiotics, pursuant to which the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.